ID 19533 | 02.05.2023
This European Commission guide provides practical examples for reducing workers’ exposure to hazardous medicinal products across all lifecycle stages: production, transport and storage, preparation, administration to human patients and animal patients as well as waste management.
The non-binding guidance offers a broad range of practical advice for workers, employers, public authorities and safety experts to underpin their approaches to workers’ protection from hazardous medicinal products.
For the purposes of this guide, hazardous medicinal products (HMPs) are defined as medicinal products that contain one or more substances that meet the criteria for classification as:
- Carcinogenic (category 1A or 1B),
- Mutagenic (category 1A or 1B) or
- Toxic for reproduction (category 1A or 1B)
in accordance with Regulation (EC) n. 1272/2008 (the CLP Regulation). This includes medicinal products for both human and veterinary use.
...
Fonte: EU OSHA 2023
List of recommended health-based biological limit values (BLVs) and biological guidance values (BGVs) Scientific Committee on Occupationa...
Attuazione delle direttive 97/42/CE e 1999/38/CE, che modificano la direttiva 90/394/CEE, in materia di protezione dei lavoratori contro i rischi derivanti da esposizion...
WHO - Interim guidance 12 February 2020 (OMS)
The purpose of this document is to provide interim guidance on laboratory biosa...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
